Kereső
Bejelentkezés
Kapcsolat
![]() |
Stability study of nasal powder formulation containing nanosized lamotrigine |
Tartalom: | https://www.aph-hsps.hu/acta/index.php/aph/article/view/23 |
---|---|
Archívum: | Acta Pharmaceutica |
Gyűjtemény: | Original Research Articles |
Cím: |
Stability study of nasal powder formulation containing nanosized lamotrigine
|
Létrehozó: |
Gieszinger, Péter
Katona, Gábor
Szabó-Révész, Piroska
Ambrus, Rita
|
Kiadó: |
Hungarian Society for Pharmaceutical Sciences
|
Dátum: |
2020-06-10
|
Téma: |
nasal delivery
stability test
nanotechnology
nasal powder
lamotrigine
formulation
|
Tartalmi leírás: |
Drug administration through the nose offers great possibilities which have been discovered in the past few decades. Besides the most known local effect, systemic and central nervous system effect is also available, the administration is non-painful and the degradation effect of the gastrointestinal tract can be avoided. Amongst the nasal formulations, powders have become more popular as their stability is favorable compared to the liquid formulations and a higher dose can be administered in powder form. The quality insurance and stability of the products in the pharmaceutical field have gained considerable attention in the last decades. Due to this fact, the aim was to execute a long-term stability study of a previously developed, nanosized lamotrigine (LAM) containing nasal powder (NP) formulation. The results of the stability test showed that the NP formulation preserved its key properties (particle size, morphology, structure and in vitro drug release) after 6 months of storage.
|
Nyelv: |
angol
|
Típus: |
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
|
Formátum: |
application/pdf
|
Azonosító: | |
Forrás: |
Acta Pharmaceutica Hungarica; Vol. 90 No. 1 (2020); 27-31
1587-1495
0001-6659
|
Kapcsolat: | |
Létrehozó: |
Copyright (c) 2020 Acta Pharmaceutica Hungarica
|